Table 1. The surgical specimens and the biopsies studied along with the of IGF-IEc expression (%).
NEN type | N | Ki-67 (%) | Specimens | IGF-IEc expression (%) |
---|---|---|---|---|
Appendiceal NEN (N=3) |
1 | 1 | Surgical Specimen | 0 |
1 | 2 | Surgical Specimen | 0 | |
1 | 3 | Lymph node | 0 | |
Colonic NEN | 1 | 2 | Surgical Specimen | 0 |
Gallbladder NEN | 1 | 6 | Surgical Specimen | 0 |
Gastric NEN (N=8) |
3 | 2 | Surgical Specimen | 0 |
1 | 5 | Surgical specimen | 0 | |
1 | 85 | Surgical Specimen | 0 | |
1 | 5 | Surgical Specimen | 10 | |
1 | 2 | Surgical Specimen | 50 | |
1 | 2 | Surgical Specimen | 100 | |
Rectosigmoidal NEN (N=1) | 1 | 50 | Surgical Specimen | 0 |
Pancreatic NEN (N=17) |
1 | 1 | Surgical Specimen | 0 |
1 | 6,50 | Surgical Specimen | 0 | |
2 | 7 | Surgical Specimen | 0 | |
1 | 17 | Surgical Specimen | 0 | |
1 | 50 | Surgical Specimen | 0 | |
1 | 55 | Liver biopsy | 0 | |
1 | 2 | Surgical Specimen | 1 | |
1 | 2.5 | Surgical Specimen | 1 | |
1 | 80 | Liver biopsy | 1 | |
1 | 2 | Surgical Specimen | 10 | |
1 | 3 | Surgical Specimen | 10 | |
1 | 6 | Liver biopsy | 10 | |
1 | 20 | Liver biopsy | 10 | |
1 | 15 | Liver biopsy | 50 | |
1 | 60 | Liver biopsy | 80 | |
1 | 6 | Liver biopsy | 100 | |
Small bowel NEN (N=9) |
2 | 1 | Surgical Specimen | 0 |
3 | 1 | Liver biopsy | 0 | |
1 | 2 | Surgical Specimen | 1 | |
1 | 5 | Surgical Specimen | 1 | |
1 | 1,5 | Liver biopsy | 10 | |
1 | 5 | Surgical Specimen | 10 | |
Lung NEC (N=2) |
1 | 50 | Surgical Specimen | 0 |
1 | 70 | Lymph node | 50 | |
Uterine cervical NEC | 1 | 70 | Surgical Specimen | 10 |
Undifferentiated NEC (Small cell) UPO | 1 | 25 | Bone marrow metastasis | 1 |
1 | 80 | Lymph node | 10 | |
Undifferentiated NEC (Large cells) UPO | 1 | 70 | Lymph node | 50 |
1 | 70 | Metastasis mediastinum | 100 | |
Total | 47 | 5 (1-85) | Origin from primary tumors (30)/ metastases (17) | 10 (1-100) |
NEN: neuroendocrine neoplasm; NEC: neuroendocrine carcinoma; UPO: unknown primary origin.